According to a recent Forbes article, Orchid Ventures, Inc. (CSE:ORCD,OTC:ORVRF) has recently announced its intent to acquire GreenBloom Cannabis Co., a vertically-integrated multistate operator, for $29 million in shares and cash. GreenBloom owns five retail stores, two cultivation facilities, one distribution entity and six brands in Oregon and California. GreenBloom founder and CEO George Mattia is expected to join the Orchid Ventures executive leadership team and board of directors once the acquisition is complete.

According to the article, GreenBloom’s holdings are expected to generate up to C$163.7 million over the next 12 months. Orchid Ventures also intends to help GreenBloom build out its cultivation, processing and retail location in California. The facility rests upon 10 acres of land and holds 300,000-square-feet of canopy and 25,000-square-feet of processing capabilities.

Forbes was able to sit down with Orchid Ventures CEO Corey Mangold to gain some insights into the deal. According to Mangold, the deal will solidify supply chains in Oregon and California for both companies. Mangold also hinted that this will be the first acquisition for Orchid Ventures and that there will be more to come.

“We’ve fostered a great relationship with GreenBloom over the past year, visiting their facilities and working closely with their management team, and the alignment of our two organizations will increase revenue and EBITDA. Orchid will now be one step closer to expanding into multiple new states and countries in the near future,” said Mangold.

To view the full article, click here.

Click here to connect with Orchid Ventures Inc. (CSE:ORCD) for an Investor Presentation.

US-based multi-state operators (MSOs) performed well during Q1, but one fund manager believes that hasn’t been reflected in their share prices.

Keep reading... Show less

 Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) announced today that its proprietary and patented combinatorial mushroom preparations AION F7 and AION F8 (collectively, the ” Aion Mushroom Preparations ” or ” Preparations “) showed high efficacy in killing HER2+ breast cancer cells, ER+PR+ breast cancer cells, and triple-negative breast cancer cells by direct cytotoxicity.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf”, “OILS”, or the “Company”) , the world’s most innovative cannabis processor, is pleased to announce that its wholly-owned subsidiary Nextleaf Labs Ltd. (“Nextleaf Labs” or “Labs”) has completed an inaugural bulk CBD distillate delivery to a U.S.-listed, Canadian-based global cannabis company. The Company anticipates similar orders on an ongoing basis.

Keep reading... Show less

The Company Will Tap into Southern Glazer’s Established Distribution Network to Bring Quatreau, its CBD-Infused Sparkling Water, to U.S. Retailers

 Canopy Growth Corporation (“Canopy Growth”) (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, CBD and vaporization device company, today announced Southern Glazer’s Wine & Spirits (“Southern Glazer’s”), the world’s pre-eminent distributor of beverage alcohol, as the distribution partner for its U.S. portfolio of CBD-infused beverages. This partnership announcement follows the recent launch of Quatreau Canopy’s first line of CBD-infused beverages sold in the U.S market.

Keep reading... Show less

 Canbud Distribution Corporation (CSE: CBDX) (FSE: CD0) (“Canbud” or the “Corporation”) announces its subsidiary Empathy Plant Co. has completed the full development of its vegan multivitamin formula exclusively for women.

Cannot view this image? Visit:
Unique Vegan Women’s Multi-Vitamin with 100% Compostable Packaging

Keep reading... Show less